List of Tables
    Table 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trends
    Table 3. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers
    Table 4. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Challenges
    Table 5. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints
    Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Paroxysmal Nocturnal Hemoglobinuria Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment as of 2021)
    Table 15. Top Players of Paroxysmal Nocturnal Hemoglobinuria Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Paroxysmal Nocturnal Hemoglobinuria Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Achillion Pharmaceuticals Inc Company Details
    Table 31. Achillion Pharmaceuticals Inc Business Overview
    Table 32. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 33. Achillion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 34. Achillion Pharmaceuticals Inc Recent Development
    Table 35. Akari Therapeutics Plc Company Details
    Table 36. Akari Therapeutics Plc Business Overview
    Table 37. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 38. Akari Therapeutics Plc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 39. Akari Therapeutics Plc Recent Development
    Table 40. Alexion Pharmaceuticals Inc Company Details
    Table 41. Alexion Pharmaceuticals Inc Business Overview
    Table 42. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 43. Alexion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 44. Alexion Pharmaceuticals Inc Recent Development
    Table 45. Alnylam Pharmaceuticals Inc Company Details
    Table 46. Alnylam Pharmaceuticals Inc Business Overview
    Table 47. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 48. Alnylam Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 49. Alnylam Pharmaceuticals Inc Recent Development
    Table 50. Amgen Inc Company Details
    Table 51. Amgen Inc Business Overview
    Table 52. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 53. Amgen Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 54. Amgen Inc Recent Development
    Table 55. Apellis Pharmaceuticals Inc Company Details
    Table 56. Apellis Pharmaceuticals Inc Business Overview
    Table 57. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 58. Apellis Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 59. Apellis Pharmaceuticals Inc Recent Development
    Table 60. F. Hoffmann-La Roche Ltd Company Details
    Table 61. F. Hoffmann-La Roche Ltd Business Overview
    Table 62. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 63. F. Hoffmann-La Roche Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 64. F. Hoffmann-La Roche Ltd Recent Development
    Table 65. ISU ABXIS Co Ltd Company Details
    Table 66. ISU ABXIS Co Ltd Business Overview
    Table 67. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 68. ISU ABXIS Co Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 69. ISU ABXIS Co Ltd Recent Development
    Table 70. Novartis AG Company Details
    Table 71. Novartis AG Business Overview
    Table 72. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 73. Novartis AG Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 74. Novartis AG Recent Development
    Table 75. NovelMed Therapeutics Inc Company Details
    Table 76. NovelMed Therapeutics Inc Business Overview
    Table 77. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 78. NovelMed Therapeutics Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 79. NovelMed Therapeutics Inc Recent Development
    Table 80. Omeros Corp Company Details
    Table 81. Omeros Corp Business Overview
    Table 82. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 83. Omeros Corp Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 84. Omeros Corp Recent Development
    Table 85. Ra Pharmaceuticals Inc Company Details
    Table 86. Ra Pharmaceuticals Inc Business Overview
    Table 87. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 88. Ra Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 89. Ra Pharmaceuticals Inc Recent Development
    Table 90. Regeneron Pharmaceuticals Inc Company Details
    Table 91. Regeneron Pharmaceuticals Inc Business Overview
    Table 92. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 93. Regeneron Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 94. Regeneron Pharmaceuticals Inc Recent Development
    Table 95. Regenesance BV Company Details
    Table 96. Regenesance BV Business Overview
    Table 97. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product
    Table 98. Regenesance BV Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
    Table 99. Regenesance BV Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Product Picture
    Figure 2. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share in Global 2017-2028
    Figure 7. Paroxysmal Nocturnal Hemoglobinuria Treatment Report Years Considered
    Figure 8. Product Picture of ACH-4471
    Figure 9. Product Picture of ALN-CC5
    Figure 10. Product Picture of ALXN-1210
    Figure 11. Product Picture of AMY-101
    Figure 12. Product Picture of APL-2
    Figure 13. Product Picture of Others
    Figure 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type in 2022 & 2028
    Figure 15. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
    Figure 17. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type in 2022 & 2028
    Figure 18. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Others
    Figure 23. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application in 2022 & 2028
    Figure 24. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
    Figure 26. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application in 2022 & 2028
    Figure 27. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
    Figure 29. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Achillion Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 58. Akari Therapeutics Plc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 59. Alexion Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 60. Alnylam Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 61. Amgen Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 62. Apellis Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 63. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 64. ISU ABXIS Co Ltd Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 65. Novartis AG Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 66. NovelMed Therapeutics Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 67. Omeros Corp Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 68. Ra Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 69. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 70. Regenesance BV Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed